Literature DB >> 18555795

Desulfated galactosaminoglycans are potential ligands for galectins: evidence from frontal affinity chromatography.

Jun Iwaki1, Toshikazu Minamisawa, Hiroaki Tateno, Junko Kominami, Kiyoshi Suzuki, Nozomu Nishi, Takanori Nakamura, Jun Hirabayashi.   

Abstract

Galectins, a group of beta-galactoside-binding lectins, are involved in multiple functions through specific binding to their oligosaccharide ligands. No previous work has focused on their interaction with glycosaminoglycans (GAGs). In the present work, affinities of established members of human galectins toward a series of GAGs were investigated, using frontal affinity chromatography. Structurally-defined keratan sulfate (KS) oligosaccharides showed significant affinity to a wide range of galectins if Gal residue(s) remained unsulfated, while GlcNAc sulfation had relatively little effect. Consistently, galectins showed much higher affinity to corneal type I than cartilageous type II KS. Unexpectedly, galectin-3, -7, and -9 also exerted significant affinity to desulfated, GalNAc-containing GAGs, i.e., chondroitin and dermatan, but not at all to hyaluronan and N-acetylheparosan. These observations revealed that the integrity of 6-OH of betaGalNAc is important for galectin recognition of these galactosaminoglycans, which were shown, for the first time, to be implicated as potential ligands of galectins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18555795     DOI: 10.1016/j.bbrc.2008.05.190

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

Review 1.  Pharmaceutical and biomedical applications of affinity chromatography: recent trends and developments.

Authors:  David S Hage; Jeanethe A Anguizola; Cong Bi; Rong Li; Ryan Matsuda; Efthimia Papastavros; Erika Pfaunmiller; John Vargas; Xiwei Zheng
Journal:  J Pharm Biomed Anal       Date:  2012-01-14       Impact factor: 3.935

Review 2.  Molecular engineering of glycosaminoglycan chemistry for biomolecule delivery.

Authors:  Tobias Miller; Melissa C Goude; Todd C McDevitt; Johnna S Temenoff
Journal:  Acta Biomater       Date:  2013-10-09       Impact factor: 8.947

3.  Exposure to common food additive carrageenan leads to reduced sulfatase activity and increase in sulfated glycosaminoglycans in human epithelial cells.

Authors:  Bo Yang; Sumit Bhattacharyya; Robert Linhardt; Joanne Tobacman
Journal:  Biochimie       Date:  2012-03-05       Impact factor: 4.079

4.  Increased expression of colonic Wnt9A through Sp1-mediated transcriptional effects involving arylsulfatase B, chondroitin 4-sulfate, and galectin-3.

Authors:  Sumit Bhattacharyya; Leo Feferman; Joanne K Tobacman
Journal:  J Biol Chem       Date:  2014-04-28       Impact factor: 5.157

Review 5.  Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progression.

Authors:  Ivan O Potapenko; Vilde D Haakensen; Torben Lüders; Aslaug Helland; Ida Bukholm; Therese Sørlie; Vessela N Kristensen; Ole C Lingjaerde; Anne-Lise Børresen-Dale
Journal:  Mol Oncol       Date:  2009-12-11       Impact factor: 6.603

6.  The carbohydrate-binding domain on galectin-1 is more extensive for a complex glycan than for simple saccharides: implications for galectin-glycan interactions at the cell surface.

Authors:  Michelle C Miller; Irina V Nesmelova; David Platt; Anatole Klyosov; Kevin H Mayo
Journal:  Biochem J       Date:  2009-06-26       Impact factor: 3.857

Review 7.  Mechanistic and therapeutic overview of glycosaminoglycans: the unsung heroes of biomolecular signaling.

Authors:  Khushboo Gulati; Krishna Mohan Poluri
Journal:  Glycoconj J       Date:  2015-12-03       Impact factor: 2.916

8.  Hypoxia reduces arylsulfatase B activity and silencing arylsulfatase B replicates and mediates the effects of hypoxia.

Authors:  Sumit Bhattacharyya; Joanne K Tobacman
Journal:  PLoS One       Date:  2012-03-13       Impact factor: 3.240

9.  Arylsulfatase B regulates versican expression by galectin-3 and AP-1 mediated transcriptional effects.

Authors:  S Bhattacharyya; L Feferman; J K Tobacman
Journal:  Oncogene       Date:  2013-11-18       Impact factor: 9.867

Review 10.  Designing the new generation of intelligent biocompatible carriers for protein and peptide delivery.

Authors:  Angela M Wagner; Margaret P Gran; Nicholas A Peppas
Journal:  Acta Pharm Sin B       Date:  2018-03-02       Impact factor: 11.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.